Author Question: Which type of malignancy is more common in children with Down's syndrome? 1. Leukemias 2. ... (Read 101 times)

jwb375

  • Hero Member
  • *****
  • Posts: 540
Which type of malignancy is more common in children with Down's syndrome?
 
  1. Leukemias
   2. Osteosarcomas
   3. Large cell carcinomas
   4. Non-small cell carcinomas

Question 2

What is menarche?
 
  1. Not something to worry about with this age group
   2. An adverse reportable condition
   3. Early menopause
   4. A girls first period, the start of menses.



epscape

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

1
Feedback
1. Leukemias are common the most common malignancy in children with Down's syndrome.
2. Osteosarcoma is not prevalent in children with Down's syndrome.
3. Large cell carcinomas are not prevalent in children with Down's syndrome.
4. Non-small cell carcinomas are rare in children with Down's syndrome.

Answer to Question 2

4
Feedback
1. Assessment for menarche is an important consideration for school-age girls.
2. This need only be assessed and documented. No reporting is necessary.
3. Menarche is not menopause. Menopause will not be found in this age group.
4. Menarche is a girl's first menses and should be assessed and documented. Supportive care and education should be supplied to the patient and parents.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The familiar sounds of your heart are made by the heart's valves as they open and close.

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

The Babylonians wrote numbers in a system that used 60 as the base value rather than the number 10. They did not have a symbol for "zero."

For a complete list of videos, visit our video library